By Luis Hakim, Manufacturing and Operations, Deloitte Consulting LLP
In a recent Deloitte Center for Health Solutions survey, 68% of medtech leaders said they lack confidence in their companies’ ability to restore disrupted supply chains quickly. Here are key practical action items to take.
This article provides a framework to streamline the biological safety assessment process, reduce testing burdens, and improve patient safety for combination products.
